Paragon 28, Inc.
DelistedCIK 1531978fmd_07PASMX3JGDBHQQ7809D3FVHN7Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2019 to Dec 31, 2024, 19 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Total revenues | 106 | 111 | 147 | 181 | 216 | 256 |
| Cost of revenue | 19 | 25 | 28 | 32 | 52 | 65 |
| Gross profit | 87 | 86 | 119 | 149 | 164 | 191 |
| Research and development | 10 | 11 | 16 | 25 | 30 | 27 |
| Selling, general and administrative | 74 | 73 | 114 | 159 | 180 | 205 |
| Total operating expenses | 85 | 84 | 130 | 211 | 210 | 232 |
| Operating income | 3 | 2 | (11) | (62) | (46) | (41) |
| Interest expense | 1 | 1 | 2 | 4 | 5 | – |
| Other non-operating income (expense) | (1) | 3 | (2) | (4) | (12) | (13) |
| Income before taxes | 2 | 5 | (13) | (66) | (57) | (53) |
| Income tax expense | (1) | 2 | 1 | (0) | 0 | 1 |
| Net income from continuing operations | 3 | 3 | (14) | (66) | (58) | (55) |
| Net income | 3 | 3 | (14) | (66) | (58) | (55) |
| Net income to common shareholders | 3 | 3 | (14) | (67) | – | – |